Arcus Biosciences (RCUS) Current Assets (2017 - 2026)
Arcus Biosciences (RCUS) recorded Current Assets of $756 million in Q2 2026, down 20.1% from $946 million a year earlier and down 10.4% from the prior quarter.
Powered by 
Analysis
Arcus Biosciences (RCUS) Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Arcus Biosciences reported Current Assets of $1.01 billion, down 0.9% from FY2024.
- Annual Current Assets has a five-year compound annual growth rate of 6.5% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $1.02 billion in FY2024 (+22.3%), $831 million in FY2023 (-22.1%), $1.07 billion in FY2022 (-15.5%) and $1.26 billion in FY2021 (+71.5%).
- The Q2 2026 figure is the lowest quarterly Current Assets since Q3 2021.
- On a year-over-year basis, Current Assets has declined for six consecutive quarters, with an average decline of 2.9% over the last eight quarters.
- Peak year-over-year performance for Current Assets in the last five years was growth of 101.9% in Q3 2022, against a decline of 31.6% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $844 million (Q1 2026), $1.01 billion (Q4 2025) and $857 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Arcus Biosciences | 3.18 Bn | -157.19 Mn | - | 756.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 756.00 Mn |
| Mar 31, 2026 | 844.00 Mn |
| Dec 31, 2025 | 1.01 Bn |
| Sep 30, 2025 | 857.00 Mn |
| Jun 30, 2025 | 946.00 Mn |
| Mar 31, 2025 | 1.03 Bn |
| Dec 31, 2024 | 1.02 Bn |
| Sep 30, 2024 | 1.13 Bn |
| Jun 30, 2024 | 1.02 Bn |
| Mar 31, 2024 | 1.06 Bn |
| Dec 31, 2023 | 831.00 Mn |
| Sep 30, 2023 | 882.00 Mn |
| Jun 30, 2023 | 986.00 Mn |
| Mar 31, 2023 | 1.02 Bn |
| Dec 31, 2022 | 1.07 Bn |
| Sep 30, 2022 | 1.10 Bn |
| Jun 30, 2022 | 1.23 Bn |
| Mar 31, 2022 | 1.26 Bn |
| Dec 31, 2021 | 1.26 Bn |
| Sep 30, 2021 | 545.29 Mn |
API Access
Arcus Biosciences Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();